Pre-treatment of wildtype C57BL/6 mice with the FPR2 antagonist WRW4 was capable of inhibiting LeishEXO-mediated immunopathogenesis, decreasing footpad swelling as well as parasitemia. Here, FPR2 is linked to parasitic infectious disease.